15th May 2006 17:00
Intl. Biotechnology Trust PLC15 May 2006 15 May 2006 PORTFOLIO COMPANY The Board of International Biotechnology Trust plc notes that the Board of thequoted portfolio company Cambridge Antibody Technology (Ticker 'CAT') has agreeda tender offer from AstraZeneca, subject to shareholder and regulatory approval. The closing price of ordinary shares in CAT on Friday, 12 May 2006 was 791p pershare and the tender offer is 1,320p per share. The current traded price is1,297p per share. Enquiries: Andy SmithSV Life Sciences Managers LLPInvestment Manager Tel: 020 7412 7067 John SpeddingSchroder Investment Management Limited Tel: 020 7658 3206 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Int.biotech.Astrazeneca